 | • レポートコード：GIR-2104Z07880 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん用体外診断 (IVD)のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん用体外診断 (IVD)の種類別市場規模（機器、試薬、キット）、用途別市場規模（研究所、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん用体外診断 (IVD)の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：MDx Health Quest Diagnostics、R-Biopharm AG、Signature Diagnostics、Siemens Healthcare、Randox Laboratories、Epigenomics AG、Beckman Coulter、Abbott Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：機器、試薬、キット ・用途別分析2016年-2026年：研究所、病院、その他 ・がん用体外診断 (IVD)の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん用体外診断 (IVD)のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん用体外診断 (IVD)のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん用体外診断 (IVD)の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん用体外診断 (IVD)の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The In-Vitro Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global In-Vitro Cancer Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global In-Vitro Cancer Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
In-Vitro Cancer Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Instruments
Reagents and Kits
Market segment by Application, can be divided into
Laboratories
Hospitals
Others
Market segment by players, this report covers
MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of In-Vitro Cancer Diagnostics
1.2 Classification of In-Vitro Cancer Diagnostics by Type
1.2.1 Overview: Global In-Vitro Cancer Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Type in 2020
1.2.3 Instruments
1.2.4 Reagents and Kits
1.3 Global In-Vitro Cancer Diagnostics Market by Application
1.3.1 Overview: Global In-Vitro Cancer Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Global In-Vitro Cancer Diagnostics Market Size & Forecast
1.5 Global In-Vitro Cancer Diagnostics Market Size and Forecast by Region
1.5.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global In-Vitro Cancer Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America In-Vitro Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe In-Vitro Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific In-Vitro Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America In-Vitro Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa In-Vitro Cancer Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 In-Vitro Cancer Diagnostics Market Drivers
1.6.2 In-Vitro Cancer Diagnostics Market Restraints
1.6.3 In-Vitro Cancer Diagnostics Trends Analysis
2 Company Profiles
2.1 MDx Health Quest Diagnostics
2.1.1 MDx Health Quest Diagnostics Details
2.1.2 MDx Health Quest Diagnostics Major Business
2.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product and Solutions
2.1.4 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 MDx Health Quest Diagnostics Recent Developments and Future Plans
2.2 R-Biopharm AG
2.2.1 R-Biopharm AG Details
2.2.2 R-Biopharm AG Major Business
2.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Product and Solutions
2.2.4 R-Biopharm AG In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 R-Biopharm AG Recent Developments and Future Plans
2.3 Signature Diagnostics
2.3.1 Signature Diagnostics Details
2.3.2 Signature Diagnostics Major Business
2.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Product and Solutions
2.3.4 Signature Diagnostics In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Signature Diagnostics Recent Developments and Future Plans
2.4 Siemens Healthcare
2.4.1 Siemens Healthcare Details
2.4.2 Siemens Healthcare Major Business
2.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Product and Solutions
2.4.4 Siemens Healthcare In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Siemens Healthcare Recent Developments and Future Plans
2.5 Randox Laboratories
2.5.1 Randox Laboratories Details
2.5.2 Randox Laboratories Major Business
2.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Product and Solutions
2.5.4 Randox Laboratories In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Randox Laboratories Recent Developments and Future Plans
2.6 Epigenomics AG
2.6.1 Epigenomics AG Details
2.6.2 Epigenomics AG Major Business
2.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Product and Solutions
2.6.4 Epigenomics AG In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Epigenomics AG Recent Developments and Future Plans
2.7 Beckman Coulter
2.7.1 Beckman Coulter Details
2.7.2 Beckman Coulter Major Business
2.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Product and Solutions
2.7.4 Beckman Coulter In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Beckman Coulter Recent Developments and Future Plans
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Product and Solutions
2.8.4 Abbott Laboratories In-Vitro Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Abbott Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-Vitro Cancer Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 In-Vitro Cancer Diagnostics Players Market Share
3.2.2 Top 10 In-Vitro Cancer Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 In-Vitro Cancer Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In-Vitro Cancer Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global In-Vitro Cancer Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2016-2021)
5.2 In-Vitro Cancer Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America In-Vitro Cancer Diagnostics Revenue by Type (2016-2026)
6.2 North America In-Vitro Cancer Diagnostics Revenue by Application (2016-2026)
6.3 North America In-Vitro Cancer Diagnostics Market Size by Country
6.3.1 North America In-Vitro Cancer Diagnostics Revenue by Country (2016-2026)
6.3.2 United States In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe In-Vitro Cancer Diagnostics Revenue by Type (2016-2026)
7.2 Europe In-Vitro Cancer Diagnostics Revenue by Application (2016-2026)
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Country
7.3.1 Europe In-Vitro Cancer Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Region (2016-2026)
8.3.2 China In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America In-Vitro Cancer Diagnostics Revenue by Type (2016-2026)
9.2 South America In-Vitro Cancer Diagnostics Revenue by Application (2016-2026)
9.3 South America In-Vitro Cancer Diagnostics Market Size by Country
9.3.1 South America In-Vitro Cancer Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE In-Vitro Cancer Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global In-Vitro Cancer Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global In-Vitro Cancer Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market In-Vitro Cancer Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global In-Vitro Cancer Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global In-Vitro Cancer Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. MDx Health Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. MDx Health Quest Diagnostics Major Business
Table 8. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product and Solutions
Table 9. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. R-Biopharm AG Corporate Information, Head Office, and Major Competitors
Table 11. R-Biopharm AG Major Business
Table 12. R-Biopharm AG In-Vitro Cancer Diagnostics Product and Solutions
Table 13. R-Biopharm AG In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Signature Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. Signature Diagnostics Major Business
Table 16. Signature Diagnostics In-Vitro Cancer Diagnostics Product and Solutions
Table 17. Signature Diagnostics In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Healthcare Major Business
Table 20. Siemens Healthcare In-Vitro Cancer Diagnostics Product and Solutions
Table 21. Siemens Healthcare In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Randox Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. Randox Laboratories Major Business
Table 24. Randox Laboratories In-Vitro Cancer Diagnostics Product and Solutions
Table 25. Randox Laboratories In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Epigenomics AG Corporate Information, Head Office, and Major Competitors
Table 27. Epigenomics AG Major Business
Table 28. Epigenomics AG In-Vitro Cancer Diagnostics Product and Solutions
Table 29. Epigenomics AG In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 31. Beckman Coulter Major Business
Table 32. Beckman Coulter In-Vitro Cancer Diagnostics Product and Solutions
Table 33. Beckman Coulter In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Abbott Laboratories Major Business
Table 36. Abbott Laboratories In-Vitro Cancer Diagnostics Product and Solutions
Table 37. Abbott Laboratories In-Vitro Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global In-Vitro Cancer Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 39. Global In-Vitro Cancer Diagnostics Revenue Share by Players (2019-2021)
Table 40. Breakdown of In-Vitro Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. In-Vitro Cancer Diagnostics Players Head Office, Products and Services Provided
Table 42. In-Vitro Cancer Diagnostics Mergers & Acquisitions in the Past Five Years
Table 43. In-Vitro Cancer Diagnostics New Entrants and Expansion Plans
Table 44. Global In-Vitro Cancer Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 45. Global In-Vitro Cancer Diagnostics Revenue Share by Type (2016-2021)
Table 46. Global In-Vitro Cancer Diagnostics Revenue Forecast by Type (2021-2026)
Table 47. Global In-Vitro Cancer Diagnostics Revenue by Application (2016-2021)
Table 48. Global In-Vitro Cancer Diagnostics Revenue Forecast by Application (2021-2026)
Table 49. North America In-Vitro Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 50. North America In-Vitro Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 51. North America In-Vitro Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 52. North America In-Vitro Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 53. North America In-Vitro Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 54. North America In-Vitro Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe In-Vitro Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe In-Vitro Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe In-Vitro Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe In-Vitro Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe In-Vitro Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe In-Vitro Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific In-Vitro Cancer Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 67. South America In-Vitro Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 68. South America In-Vitro Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 69. South America In-Vitro Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 70. South America In-Vitro Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 71. South America In-Vitro Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 72. South America In-Vitro Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa In-Vitro Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. In-Vitro Cancer Diagnostics Picture
Figure 2. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type in 2020
Figure 3. Instruments
Figure 4. Reagents and Kits
Figure 5. In-Vitro Cancer Diagnostics Revenue Market Share by Application in 2020
Figure 6. Laboratories Picture
Figure 7. Hospitals Picture
Figure 8. Others Picture
Figure 9. Global In-Vitro Cancer Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global In-Vitro Cancer Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global In-Vitro Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 12. Global In-Vitro Cancer Diagnostics Revenue Market Share by Region in 2020
Figure 13. North America In-Vitro Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe In-Vitro Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific In-Vitro Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America In-Vitro Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. In-Vitro Cancer Diagnostics Market Drivers
Figure 18. In-Vitro Cancer Diagnostics Market Restraints
Figure 19. In-Vitro Cancer Diagnostics Market Trends
Figure 20. MDx Health Quest Diagnostics Recent Developments and Future Plans
Figure 21. R-Biopharm AG Recent Developments and Future Plans
Figure 22. Signature Diagnostics Recent Developments and Future Plans
Figure 23. Siemens Healthcare Recent Developments and Future Plans
Figure 24. Randox Laboratories Recent Developments and Future Plans
Figure 25. Epigenomics AG Recent Developments and Future Plans
Figure 26. Beckman Coulter Recent Developments and Future Plans
Figure 27. Abbott Laboratories Recent Developments and Future Plans
Figure 29. Global In-Vitro Cancer Diagnostics Revenue Share by Players in 2020
Figure 30. In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players In-Vitro Cancer Diagnostics Revenue Market Share in 2020
Figure 32. Global Top 10 Players In-Vitro Cancer Diagnostics Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global In-Vitro Cancer Diagnostics Revenue Share by Type in 2020
Figure 35. Global In-Vitro Cancer Diagnostics Market Share Forecast by Type (2021-2026)
Figure 36. Global In-Vitro Cancer Diagnostics Revenue Share by Application in 2020
Figure 37. Global In-Vitro Cancer Diagnostics Market Share Forecast by Application (2021-2026)
Figure 38. North America In-Vitro Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 39. North America In-Vitro Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 40. North America In-Vitro Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 41. United States In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe In-Vitro Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 45. Europe In-Vitro Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 46. Europe In-Vitro Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 47. Germany In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific In-Vitro Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific In-Vitro Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific In-Vitro Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 55. China In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America In-Vitro Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 62. South America In-Vitro Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 63. South America In-Vitro Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 64. Brazil In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa In-Vitro Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa In-Vitro Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa In-Vitro Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 69. Turkey In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE In-Vitro Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界のがん体外診断市場規模・現状・予測（2021年-2027年） In-vitro cancer diagnostics is a technique in which the reagents and medical devices are employed to examine specimens such as body fluids, tissues, stool, urine, and blood. Market Analysis and Insights: Global In-Vitro Cancer Diagnostics Market The global In-Vitro Cancer Diagnostics market size is …- 世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 世界の体外診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-vitro Diagnostics Market The global In-vitro Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の体外診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-vitro Diagnostics Market The global In-vitro Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の体外診断用医薬品（IVD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In Vitro Diagnostics (IVD) Market The global In Vitro Diagnostics (IVD) market size is projected to reach US$ 120900 million by 2026, from US$ 76910 million in 2019, at a CAGR of 6.6% during 2021-2026. With industry-standard accuracy in analysis and high data int…